![Trial sets up wider use of Bayer's Nubeqa in prostate cancer](/sites/default/files/styles/x_large/public/2024-07/Nubeqa.jpg?itok=d8OUSVI5)
Trial sets up wider use of Bayer's Nubeqa in prostate cancer
Bayer has the result it was hoping for in the phase 3 ARANOTE trial of Nubeqa in metastatic, hormone-sensitive prostate cancer (mHSPC), a key part of its plan to build the drug into a €3 bi